Enzon Pharmaceuticals Inc
OTC:ENZN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Enzon Pharmaceuticals Inc
Common Stock
Enzon Pharmaceuticals Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
Common Stock
$45.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
60%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Stock
$18m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Stock
$1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Stock
$2.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Stock
$101.8k
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Enzon Pharmaceuticals Inc
Glance View
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cranford, New Jersey and currently employs 0 full-time employees. The firm intends to become an acquisition platform. The firm utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. The company manages its source of royalty revenues from existing licensing arrangements with other companies.
See Also
What is Enzon Pharmaceuticals Inc's Common Stock?
Common Stock
45.3m
USD
Based on the financial report for Dec 31, 2025, Enzon Pharmaceuticals Inc's Common Stock amounts to 45.3m USD.
What is Enzon Pharmaceuticals Inc's Common Stock growth rate?
Common Stock CAGR 10Y
60%
Over the last year, the Common Stock growth was 5%. The average annual Common Stock growth rates for Enzon Pharmaceuticals Inc have been 2% over the past three years , 2% over the past five years , and 60% over the past ten years .
